Wnt/β-Catenin Signaling Mechanisms in Cancer and Development

The Wnt/β-catenin pathway is a fundamental signalling cascade that orchestrates cell fate determination, tissue patterning and stem cell maintenance throughout embryonic development and adult homeostasis. Activation begins when secreted Wnt glycoproteins bind Frizzled family receptors and co-receptors LRP5/6, leading to recruitment of Dishevelled and inhibition of the β-catenin destruction complex (comprising APC, Axin, GSK3β and CK1). Stabilised β-catenin accumulates in the cytoplasm and translocates into the nucleus, where it partners with TCF/LEF transcription factors to induce target genes controlling proliferation, differentiation and survival. Dysregulation of this cascade—through mutations in APC or β-catenin, overexpression of Wnt ligands or aberrant co-receptor function—drives oncogenesis in colorectal, hepatic, breast and other cancers by promoting stemness, metastasis and therapeutic resistance. Recent advances have elucidated receptor conformational micro-switches that govern pathway selectivity, the modular design and robustness imparted by scaffold proteins, and the interplay between canonical and non-canonical Wnt branches. These insights underpin the development of small molecules, antibodies and peptide mimetics aimed at ligand–receptor interfaces, destruction complex stabilisation and transcriptional blockade, offering new avenues for precision oncology and regenerative medicine.

Research from Nature Portfolio

In a structure-driven mutagenesis study, investigators identified conserved state-stabilising residues in the Frizzled5 receptor that dictate preferential coupling to Dishevelled rather than heterotrimeric G proteins. Comparative molecular dynamics simulations of wild-type and mutant receptors revealed distinct active-state conformers that specify downstream pathway selection. Extrapolation to other Frizzled paralogs confirmed that these micro-switches are broadly conserved, refining our understanding of receptor-level control and presenting conformational states as targets for pathway-specific modulators.

Wnt/β-Catenin Signaling Mechanisms in Cancer and Development publication trend

The graph below shows the total number of articles in wnt/β-catenin signaling mechanisms in cancer and development across all publications each year (not limited to Nature Index journals).

Technical terms

Wnt ligand: A family of secreted glycoproteins that initiate signalling by binding Frizzled receptors and LRP co-receptors.

Frizzled receptor: A class of seven-transmembrane receptors that transduce Wnt signals by engaging Dishevelled and co-receptors.

Dishevelled (DVL): A cytoplasmic phosphoprotein that relays activated receptor signals to inhibit the β-catenin destruction complex.

β-Catenin destruction complex: A multiprotein assembly (APC, Axin, GSK3β, CK1) that phosphorylates and targets β-catenin for proteasomal degradation in the absence of Wnt.

TCF/LEF transcription factors: Nuclear DNA-binding proteins that partner with stabilised β-catenin to activate Wnt target gene expression.

References

1. Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining, active conformations. Nature Communications (2023).
2. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduction and Targeted Therapy (2022).
3. Targeting the Wnt/β-catenin signaling pathway in cancer. Journal of Hematology & Oncology (2020).
4. Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling. BMC Genomics (2014).